A.I.-Driven Chip Crunch Leads to New Rush of Lobbying in Washington

Researchers say breakthrough offers hope for new medicines but also raises urgent biosecurity questions Scientists have made the first viruses designed by artificial intelligence in a milestone that raises hopes for new medicines but also concerns over how to ensure the technology remains safe. The viruses are specific kinds known as bacteriophages, which only infect bacteria and are used around the world to treat patients with persistent infections. In lab tests, a cocktail of the AI-designed viruses killed E coli bugs that were resistant to natural bacteriophages...

A Trump administration framework on AI testing leaves a lack of transparency – and plenty of open questions After months of talking with tech industry leaders, the Trump administration finalized a framework this week for how it will test new artificial intelligence models for safety and cybersecurity risks. So far, the White House is keeping details of the framework private, in a blow to transparency and potential boon for secretive AI companies. On Tuesday, staff from OpenAI, Anthropic, Meta, Google, Nvidia and Microsoft attended a private meeting with White House officials to review the AI framework. Multiple outlets have since reported that although the volunteer vetting process for new AI models has been settled, the White House does not plan to release its policy publicly and will only share testing criteria with a select few tech companies...

Apollo, BlackRock, Goldman Sachs and KKR among those working with chipmaker to fund infrastructure Nvidia ⁠has partnered with six major Wall Street financial institutions to raise ⁠more than $500bn (£370bn) capital for artificial intelligence infrastructure. The Nvidia chief executive, Jensen Huang, said on X that the company has ⁠the option to backstop up to $125bn, or 25% of the potential deals...